FYCOMPA 6 mg

Indications

• Adjunctive treatment of focal seizures with or without secondary generalised seizures
• Adjunctive treatment of primary generalised tonic-clonic seizures

Dosage

Children: Child 12–17 years: Initially 2 mg once daily, dose to be taken before bedtime, increased if tolerated in steps of 2 mg at intervals of at least every 2 weeks, adjusted according to response; maintenance 4–8 mg once daily; maximum 12 mg per day.

Adults: Initially 2 mg once daily, dose to be taken before bedtime, increased if tolerated in steps of 2 mg at intervals of at least every 2 weeks, adjusted according to response; maintenance 4–8 mg once daily; maximum 12 mg per day.

Mechanism of action

Perampanel decreases neuronal excitation through non-competitive inhibition of the AMPA receptor, which is implicated in the pathophysiology of seizure disorders.

Pharmacodynamics

Perampanel's pharmacodynamics involve the inhibition of excitatory neurotransmission in the central nervous system, which leads to a decrease in psychomotor performance and seizure activity. The full extent of its action on neuronal circuits remains to be fully elucidated.

Pharmacokinetics

Perampanel is well absorbed after oral administration, with peak plasma concentrations typically reached within 0.5 to 1.5 hours. It is extensively metabolized in the liver, primarily by CYP3A4. The elimination half-life is approximately 105 hours, allowing for once-daily dosing. The drug's clearance can be affected by concomitant use of other medications that induce or inhibit CYP3A4.

Contra-indications

• Hypersensitivity to perampanel or any of its components
• Severe hepatic impairment

Adverse effects

• Dizziness
• Somnolence
• Fatigue
• Irritability
• Nausea
• Vomiting
• Weight gain
• Skin reactions (e.g. rash)
• Neutropenia
• Psychiatric disorders (e.g. aggression, hostility, anxiety)

Interactions

• Mitotane - Moderate (decreases exposure)
• St. John's Wort - Moderate (decreases exposure)
• Rifampicin - Moderate (decreases exposure)

Precautions

• Monitor for signs of psychiatric disorders
• Use caution in patients with a history of substance use disorder
• Monitor plasma sodium concentration in patients at risk of hyponatraemia
• Consider HLA-B*1502 testing in certain Asian populations

Pregnancy

Clinical response should be monitored during pregnancy, and plasma concentration of the active metabolite should be considered for monitoring.

Breast-feeding

Amount probably too small to be harmful, but manufacturer advises to avoid.

Storage

Store at room temperature, away from moisture and heat.

Formulations

• Tablets: 2 mg, 4 mg, 6 mg, 8 mg

Indications

• Constipation
• Dietary fiber supplementation
• Irritable bowel syndrome
• Diverticular disease
• Weight management

Dosage

Children: Refer to appropriate guidelines for specific dosage; generally taken with adequate fluid intake.

Adults: Refer to appropriate guidelines for specific dosage; generally taken with adequate fluid intake.

Mechanism of action

Cellulose acts primarily as a bulk-forming laxative. It absorbs water in the intestines, which increases stool bulk and stimulates peristalsis, thus facilitating bowel movements. Additionally, cellulose is not digestible by human enzymes, leading to fermentation by gut bacteria, which may enhance gut health and alter gut microbiota composition.

Pharmacodynamics

Cellulose increases stool weight and frequency of bowel movements. It works by retaining water in the intestines, leading to softer stools and improved passage through the gastrointestinal tract. The bulking effect of cellulose can help alleviate constipation and promote overall digestive health. It may also play a role in cholesterol reduction and glycemic control through its effects on digestion and absorption of nutrients.

Pharmacokinetics

Cellulose is not absorbed into the bloodstream due to its indigestible nature. Instead, it passes through the gastrointestinal tract, where it adds bulk to the stool. Its fermentation by colonic bacteria produces short-chain fatty acids, which may have beneficial effects on colon health. The onset of action for cellulose as a laxative can vary but is generally within 24 to 72 hours after ingestion.

Adverse effects

• Bloating
• Flatulence
• Diarrhea
• Abdominal discomfort

Precautions

• Use with caution in patients with a history of gastrointestinal disorders.
• Monitor for potential allergic reactions in sensitive individuals.

Pregnancy

Cellulose is generally considered safe during pregnancy as it is a non-toxic, indigestible fiber.

Breast-feeding

Cellulose is also considered safe during breastfeeding; it is excreted in breast milk in negligible amounts.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powder
• Capsules
• Tablets
• Granules

Indications

• Lactose intolerance
• As a filler or excipient in pharmaceutical formulations

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and clinical context.

Adults: Refer to the BNF for specific dosing information based on clinical context.

Mechanism of action

Lactose is metabolized in the intestine by the enzyme lactase into its constituent monosaccharides, glucose and galactose. In individuals with lactase deficiency, unabsorbed lactose passes into the colon, where it is fermented by bacteria, leading to gas production and osmotic effects that contribute to diarrhea.

Pharmacodynamics

The pharmacodynamics of lactose are primarily related to its effects on gastrointestinal function. In healthy individuals, lactose is effectively broken down into glucose and galactose, which are absorbed and utilized for energy. In individuals with lactose intolerance, the unabsorbed lactose can cause osmotic diarrhea and colonic fermentation, leading to discomfort and symptoms associated with lactose intolerance.

Pharmacokinetics

Lactose is not absorbed in the gastrointestinal tract until it is hydrolyzed into glucose and galactose by lactase. The absorption of glucose and galactose occurs in the small intestine. The half-life is not applicable as lactose is not typically administered as a medication but is rather ingested as a natural component of food. Its metabolism primarily occurs in the intestine.

Adverse effects

• Bloating
• Diarrhea
• Abdominal pain
• Flatulence

Precautions

• Use with caution in patients with lactose intolerance.
• Consider potential for gastrointestinal upset in sensitive individuals.

Pregnancy

Lactose is generally considered safe for use during pregnancy. However, consult a healthcare professional for individual advice.

Breast-feeding

Lactose is safe to use while breastfeeding, as it is a natural sugar present in breast milk.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Powder
• Granules
• Tablets
• Syrup

Indications

• Hypomagnesemia
• Magnesium deficiency
• Cardiac arrhythmias
• Eclampsia
• Asthma exacerbations
• Migraine prophylaxis

Dosage

Children: Refer to the BNF for Children for pediatric dosing recommendations.

Adults: Refer to clinical guidelines or specific product information for adult dosing.

Mechanism of action

Magnesium acts as a cofactor for over 300 enzymatic reactions in the body. It is essential for ATP production, the synthesis of nucleic acids, and the regulation of calcium homeostasis. By modulating calcium channels and neurotransmitter release, magnesium influences neuromuscular transmission and muscle contraction. It also plays a role in stabilizing cellular membranes and protecting against oxidative stress.

Pharmacodynamics

Magnesium's pharmacodynamics involve its effects on various physiological processes, particularly in the cardiovascular and neuromuscular systems. It helps to maintain normal muscle and nerve function and influences cardiac rhythm. Magnesium is known to inhibit excessive calcium influx into cells, thus contributing to vasodilation and lowering blood pressure. It also has a calming effect on the nervous system, which can help alleviate anxiety and promote relaxation.

Pharmacokinetics

Magnesium is absorbed primarily in the small intestine, with the efficiency of absorption being influenced by dietary factors and the presence of other minerals. The body regulates magnesium levels through renal excretion and intestinal absorption. The half-life of magnesium varies depending on the route of administration, with intravenous administration leading to quicker distribution and elimination. The majority of magnesium is stored in the bones, muscles, and soft tissues, with only a small fraction present in the extracellular fluid.

Contra-indications

• Severe renal impairment
• Myasthenia gravis
• Hypocalcemia
• Hypophosphatemia

Adverse effects

• Diarrhea
• Nausea
• Vomiting
• Abdominal cramping
• Hypotension
• Bradypnea
• Muscle weakness

Interactions

• Antibiotics (e.g., tetracyclines, fluoroquinolones) - may bind and reduce their absorption
• Calcium supplements - may compete for absorption
• Diuretics (especially loop diuretics) - can increase the risk of magnesium deficiency
• ACE inhibitors - may enhance the hypotensive effect
• Neuromuscular blocking agents - may potentiate their effects

Precautions

• Use with caution in patients with renal impairment
• Monitor electrolytes in patients with gastrointestinal losses
• Avoid in patients with heart block
• Caution in elderly patients due to potential for electrolyte imbalance

Pregnancy

Magnesium is generally considered safe during pregnancy and is often recommended for certain conditions, such as preeclampsia.

Breast-feeding

Magnesium is excreted in breast milk but is generally considered safe for use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Oral solution
• Intravenous injection
• Intramuscular injection

Indications

• Used as an excipient in tablet formulations
• Used as a bulking agent in capsule formulations
• Used in food products as a thickener or stabilizer

Dosage

Children: Refer to specific product guidelines as dosage will depend on the formulation and the active ingredients.

Adults: Refer to specific product guidelines as dosage will depend on the formulation and the active ingredients.

Mechanism of action

Microcrystalline cellulose acts as a non-digestible filler that enhances the flow properties of powders during the manufacturing of tablets and capsules. It does not have a direct pharmacological action on the body but ensures that the active ingredients are effectively delivered to the patient.

Pharmacodynamics

As a non-active ingredient, microcrystalline cellulose does not exert pharmacodynamic effects typical of active pharmaceutical ingredients. Its primary role is to provide a stable and consistent matrix for the drug, facilitating the release of the active compound once ingested.

Pharmacokinetics

Microcrystalline cellulose is not absorbed in the gastrointestinal tract; it passes through the digestive system largely unchanged. It adds bulk to the stool, which may aid in promoting regular bowel movements. The substance is excreted in feces, where it contributes to dietary fiber intake.

Pregnancy

Data regarding the use of microcrystalline cellulose during pregnancy is limited. It is advisable to consult with healthcare professionals before use.

Breast-feeding

Microcrystalline cellulose is considered safe during breastfeeding, as it is not absorbed systemically.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Indications

• Tablet coating
• Granule coating
• Improvement of drug stability
• Taste masking
• Aesthetic enhancement of pharmaceuticals

Dosage

Children: Dosage will depend on the specific formulation and active ingredients of the medication being coated. Refer to the specific product information for guidance.

Adults: Dosage will depend on the specific formulation and active ingredients of the medication being coated. Refer to the specific product information for guidance.

Mechanism of action

Opadry functions primarily as a coating polymer that adheres to the surface of tablets or granules, creating a protective layer. This layer can control the release of the active ingredient and protect it from environmental factors such as moisture and light. The specific composition of Opadry can vary, but it typically includes film-forming agents, plasticizers, and colorants that work together to achieve the desired coating characteristics.

Pharmacodynamics

The pharmacodynamics of Opadry is largely focused on its physical and chemical properties rather than specific biological interactions. The coating alters the dissolution characteristics of the drug, potentially leading to modified release profiles. This can enhance drug bioavailability or control the release rate of the active ingredient, thereby impacting the therapeutic effect.

Pharmacokinetics

As a coating agent, Opadry itself is not absorbed into the systemic circulation and does not have pharmacokinetic properties related to absorption, distribution, metabolism, or excretion of an active pharmaceutical ingredient. Its impact on pharmacokinetics is indirect, as it affects how the active drug is released and absorbed in the gastrointestinal tract.

Pregnancy

Opadry is a film-coating agent, and specific studies on its effects during pregnancy are not well-documented. Generally, it is advisable to use medications cautiously during pregnancy. Consult a healthcare provider for guidance.

Breast-feeding

Limited data are available regarding the safety of Opadry during breastfeeding. It is recommended to consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Formulations

• Opadry OY - a coating system for oral solid dosage forms
• Opadry II - a polymer-based coating system for tablet and capsule applications

Mechanism of action

The exact mechanism of action for Pink is not detailed in the provided information. However, compounds with similar structures often function as antagonists or inhibitors at certain receptors or enzymes, which modulates physiological processes.

Pharmacodynamics

Pharmacodynamics details for Pink are not specified. Typically, the pharmacodynamics of similar compounds involve interactions with neurotransmitter systems, influencing both central and peripheral nervous system functions. This can lead to varying therapeutic effects depending on the target receptors.

Pharmacokinetics

The pharmacokinetics of Pink, including absorption, distribution, metabolism, and excretion, are not explicitly stated. However, compounds of this nature generally exhibit moderate to high oral bioavailability, with metabolism primarily occurring in the liver, followed by renal excretion of metabolites.

Indications

• Topical antiseptic for skin disinfection
• Surgical scrubs and hand sanitizers
• Wound care management
• Pharmaceutical excipient in solid and liquid formulations

Dosage

Children: Refer to specific product guidelines for pediatric dosing recommendations, as doses can vary based on formulation and intended use.

Adults: Refer to specific product guidelines for dosing recommendations, as doses can vary based on the formulation and intended use.

Mechanism of action

Povidone acts by forming a complex with iodine when used as an antiseptic, which releases iodine slowly to exert its antimicrobial effect. The iodine disrupts microbial cell walls and interferes with protein synthesis, leading to cell death. Additionally, as a polymer, povidone can enhance drug solubility and stability by forming a hydrophilic matrix.

Pharmacodynamics

Povidone has a broad spectrum of antimicrobial activity against bacteria, viruses, and fungi. Its antiseptic properties are primarily due to the release of iodine, which is effective in reducing microbial load and preventing infection. The polymer's ability to bind to various substances allows it to be utilized in formulations that require improved stability and solubility.

Pharmacokinetics

Povidone is not absorbed systemically when applied topically, as it remains localized at the site of application. Its pharmacokinetics are largely dependent on the formulation and route of administration, with the polymer being metabolized by hydrolysis and excreted in urine as low-molecular-weight compounds. The release and activity of iodine are influenced by the concentration of povidone and the presence of organic matter.

Adverse effects

• Local irritation
• Allergic reactions
• Skin rashes
• Hypersensitivity reactions

Precautions

• Use with caution in patients with known allergies to iodine or povidone-iodine
• Avoid use in deep puncture wounds or serious burns

Pregnancy

Povidone is generally considered safe for use during pregnancy, but it is advisable to consult a healthcare professional before use.

Breast-feeding

Povidone is considered safe during breastfeeding, but it is recommended to consult a healthcare professional.

Storage

Store at room temperature, away from moisture and heat. Keep the container tightly closed.

Formulations

• Topical solution
• Ointment
• Surgical scrub
• Gauze impregnated with povidone-iodine

Dosage

Children: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Adults: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Mechanism of action

The mechanism of action for purified compounds varies widely depending on the specific substance. Generally, purified drugs exert their effects by interacting with specific biological targets, such as receptors, enzymes, or ion channels, leading to a desired therapeutic effect. This interaction can involve binding to receptors to activate or inhibit signaling pathways, modulating enzymatic activity, or altering physiological processes.

Pharmacodynamics

Pharmacodynamics describes the effects of a drug on the body and the relationship between drug concentration and effect. For purified drugs, this can involve dose-response relationships and the time course of their action. The purified form often enhances potency and reduces variability in response among patients, which can lead to more predictable therapeutic outcomes. The overall effect is determined by the drug's affinity for its target, the efficacy of the drug-receptor interaction, and the downstream signaling pathways activated as a result of this interaction.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of a drug. For purified substances, absorption can be more efficient due to the absence of impurities that may affect solubility or stability. Distribution may also be enhanced, leading to higher bioavailability. Metabolism can be influenced by the structure of the purified compound, as it may be metabolized more readily by liver enzymes. Excretion typically occurs through the kidneys or liver, depending on the molecular characteristics of the purified drug.

Pregnancy

Consult with a healthcare professional, as the safety of purified forms of medications during pregnancy may vary depending on the specific substance.

Breast-feeding

Consult with a healthcare professional, as the safety of purified forms of medications during breastfeeding may vary depending on the specific substance.

Storage

Store in a cool, dry place, away from light and moisture, and keep out of reach of children.

Indications

• Thickening agent
• Stabilizer in pharmaceutical formulations
• Emulsifier in topical and oral medications

Dosage

Children: Refer to specific product guidelines, as dosing can vary based on formulation and indication.

Adults: Refer to specific product guidelines, as dosing can vary based on formulation and indication.

Mechanism of action

Substituted hydroxypropyl functions through the formation of hydrogen bonds within the polymeric structure, which increases viscosity and stabilizes emulsions. Its hydrophilic nature allows it to interact with water and other solvents, leading to improved formulation stability and bioavailability.

Pharmacodynamics

The pharmacodynamics of substituted hydroxypropyl relate primarily to its physical properties as a polysaccharide. It does not exert pharmacological effects in the traditional sense but influences the release profile of active pharmaceutical ingredients, thereby affecting their therapeutic outcomes.

Pharmacokinetics

Substituted hydroxypropyl is not absorbed systemically when used as an excipient, as it remains in the gastrointestinal tract or at the application site. It is metabolized minimally, if at all, and is excreted unchanged. Its action is predominantly local at the site of application or within the gastrointestinal lumen.

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and potential benefits outweigh risks.

Breast-feeding

It is not known whether substituted hydroxypropyl is excreted in human milk. Caution is advised when administered to nursing women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Mechanism of action

The exact mechanism of action of perampanel in seizures is not yet determined, but it is known that perampanel decreases neuronal excitation by non-competitive ihibition of the AMPA receptor.

Pharmacodynamics

Perampanel is involved in inhibiting neuronal excitation in the central nervous system leading to such effects as decreased pyschomotor performance.